Communicating with government officials on policies and/or programs that support life science research and development conducted in Canada, including manufacturing and workforce development, including measures pertaining to Canadas Biomanufacturing and Life Sciences Strategy. Communicating, in general, with officials about research, development and innovation in Canada's life sciences and biopharmaceutical sectors, including the impact these sectors have on the Canadian economy and health of Canadians. Domestic and international trade policies in support of the biopharmaceutical industry, including competitive and predictable intellectual property protection, product regulation and patient access to medicines. Advocacy as it relates to the US Administrations Most Favored Nation drug pricing policy and its potential impact for Canada Communicating with government officials on Bill S-243, An Act to establish a national framework for womens health in Canada. Providing guidance, subject matter expertise and relevant information to help inform future policy development.